It also successfully launched RHEA Generics, a brand of generic medicines developed in partnership with global leaders in the pharmaceutical industry, namely Pfizer, Sanofi, GSK, Otsuka, Merck, and Fresenius Kabi. These game-changing partnerships help Filipino patients to have access to world-class quality and affordably priced medicines. President and Chief Executive Officer, Neogin Aguilar Evangelista says, “In the five years since I joined the company, we have grown the business by almost PHP 2.1 billion in gross revenue, from PHP four billion in 2013 to PHP 6.079 billion in 2018, representing a growth of more than 50 percent. My dream when I inherited PHILUSA was to transform the company from ‘good’ to ‘great’. To accomplish this goal, we needed to change the people’s mindset from settling for current success to striving for potential growth and even more success. We inculcated a mindset of hunger and competitiveness, built competencies, improved the system and processes, promoted stronger cross-functional collaboration, and developed the business through partnerships and stronger relationships with suppliers and other business partners. As a result, in five years, the company achieved more than it had in the 57 years it had been operating before I first joined.”